Bipolar Disorder

• 

  Subject Areas on Research

  • A 13-week, randomized double-blind, placebo-controlled, cross-over trial of ziprasidone in bipolar spectrum disorder. 
  • A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state. 
  • A case of intermittent delirious mania. 
  • A factor analysis of the signs and symptoms of mania. 
  • A family history study of twenty probands with childhood manic-depressive illness. 
  • A follow-up study of post partum illness, 1946-1978. 
  • A history of the concept of atypical depression. 
  • A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. 
  • A new and timely delusion: the complaint of having AIDS. 
  • A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. 
  • A prospective study examining the effects of gender and sexual/physical abuse on mood outcomes in patients with co-occurring bipolar I and substance use disorders. 
  • A prospective study of inter-episode consistency of manic and mixed subtypes of bipolar disorder. 
  • A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression. 
  • A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force. 
  • A review of factors associated with greater likelihood of suicide attempts and suicide deaths in bipolar disorder: Part II of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. 
  • A statistical analysis of the classification of depression in a mixed community and clinical sample. 
  • Abnormal cortisol suppression in bipolar patients with simultaneous manic and depressive symptoms. 
  • Adjunctive risperidone, olanzapine and quetiapine for the treatment of hospitalized patients with bipolar I disorder: a retrospective study. 
  • Adjunctive use of olanzapine in mood disorders: five case reports. 
  • Affective disorders in five United States communities. 
  • Affective illness and HLA frequencies: no compelling association. 
  • Age of first onset of bipolar disorder: demographic, family history, and psychosocial correlates. 
  • Age-dependent reduction of amygdala volume in bipolar disorder. 
  • Allelic differences between Europeans and Chinese for CREB1 SNPs and their implications in gene expression regulation, hippocampal structure and function, and bipolar disorder susceptibility. 
  • Alprazolam-induced manic reaction. 
  • Amygdala activation during emotion processing of neutral faces in children with severe mood dysregulation versus ADHD or bipolar disorder. 
  • An American validation study of the Newcastle diagnostic scale. I. Relationship with the dexamethasone suppression test. 
  • An evaluation of the Feighner criteria for schizophrenia and affective disorders using long-term outcome data. 
  • An evidence synthesis of care models to improve general medical outcomes for individuals with serious mental illness: a systematic review. 
  • An evidence-based medicine strategy for achieving remission in bipolar disorder. 
  • An open-label trial of adjunctive oxcarbazepine for bipolar disorder. 
  • Anticipating DSM-V: opportunities and challenges for cognition and psychosis. 
  • Antidepressant treatment practice in the face of STAR*D and STEP-BD. 
  • Antidepressant treatment response in bipolar II disorder. 
  • Anxiety as a symptom of mixed mania: implications for DSM-5. 
  • Anxiety/depression: current management and future directions. Biologic markers and treatment response. 
  • Applications of TMS to therapy in psychiatry. 
  • Aripiprazole: pharmacology, efficacy, safety and tolerability. 
  • Association of the trace amine associated receptor 6 (TAAR6) gene with schizophrenia and bipolar disorder in a Korean case control sample. 
  • Associations between residence at birth and mental health disorders: a spatial analysis of retrospective cohort data. 
  • Associations between variants near a monoaminergic pathways gene (PHOX2B) and amygdala reactivity: a genome-wide functional imaging study. 
  • Atypical depression. 
  • Autophosphorylation of CaMKK2 generates autonomous activity that is disrupted by a T85S mutation linked to anxiety and bipolar disorder. 
  • Bariatric surgery in patients with bipolar spectrum disorders: Selection factors, postoperative visit attendance, and weight outcomes. 
  • Behavior and emotion modulation deficits in preschoolers at risk for bipolar disorder. 
  • Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit. 
  • Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report. 
  • Beyond symptom counts to case-wise probabilities. 
  • Biological 'markers' for endogenous depression. Effect of age, severity of illness, weight loss, and polarity. 
  • Biological markers for endogenous depression in series and parallel. 
  • Bipolar Depression: Pregnancy, Postpartum, and Lactation. 
  • Bipolar Disorder and Dementia: Weighing the Evidence. 
  • Bipolar disorder is associated with HIV transmission risk behavior among patients in treatment for HIV. 
  • Bipolar disorder, brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and brain morphology. 
  • Brain mechanisms in manic depression. 
  • Brief pulse and ultrabrief pulse right unilateral electroconvulsive therapy (ECT) for major depression: efficacy, effectiveness, and cognitive effects. 
  • Candidate gene analysis of 21q22: support for S100B as a susceptibility gene for bipolar affective disorder with psychosis. 
  • Carbamazepine extended-release capsules: a new treatment option for bipolar I disorder. 
  • Case report of treatment of severe mood disorder in an inpatient setting: when less is more. 
  • Case report: Successful riluzole augmentation therapy in treatment-resistant bipolar depression following the development of rash with lamotrigine. 
  • Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder. 
  • Case-control association study of GRIA1, GRIA2 and GRIA4 polymorphisms in bipolar disorder. 
  • Caudate volume measurement in older adults with bipolar disorder. 
  • Causes of death in schizophrenia and manic-depression. 
  • Cerebrospinal fluid and plasma free cortisol concentrations in depression. 
  • Characterization of a Human-Specific Tandem Repeat Associated with Bipolar Disorder and Schizophrenia. 
  • Cherry-picking by trialists and meta-analysts can drive conclusions about intervention efficacy. 
  • Childhood IQ and adult mental disorders: a test of the cognitive reserve hypothesis. 
  • Cholinergic reversal of manic symptoms. 
  • Clinical variables associated with early administration of antipsychotics in bipolar mania. 
  • Clinical, demographic and social characteristics of psychotic depression. 
  • Cognitive burden of anticholinergic medications in psychotic disorders. 
  • Cognitive effects of quetiapine XR in patients with euthymic bipolar disorder. 
  • Collaborative mental health and primary care for bipolar disorder. 
  • Combining gene expression, demographic and clinical data in modeling disease: a case study of bipolar disorder and schizophrenia. 
  • Comments on "Addition of lamotrigine to valproic acid: a successful outcome in a case of rapid-cycling bipolar affective disorder". 
  • Comparison of early and delayed inpatient dexamethasone suppression tests. 
  • Comparison of plasma cortisol and corticosterone in the dexamethasone suppression test for melancholia. 
  • Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT. 
  • Conceptual and methodological issues in designing a randomized, controlled treatment trial for geriatric bipolar disorder: GERI-BD. 
  • Concordance of self-rated and observer-rated dysphoric symptoms in mania. 
  • Convergent validity of the Timeline Followback for persons with comorbid psychiatric disorders engaged in residential substance use treatment. 
  • Convulsive threshold differences in right unilateral and bilateral ECT. 
  • Correlation of family history with specific autistic subgroups: Asperger's syndrome and bipolar affective disease. 
  • Cortical and subcortical white matter abnormalities in adults with remitted first-episode mania revealed by Tract-Based Spatial Statistics. 
  • Cortical white matter microstructural abnormalities in bipolar disorder. 
  • DAOA variants on diagnosis and response to treatment in patients with major depressive disorder and bipolar disorder. 
  • DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients. 
  • Decision model for the acute treatment of mania. 
  • Decrease in speech pause times with treatment of endogenous depression. 
  • Deficiency of Shank2 causes mania-like behavior that responds to mood stabilizers. 
  • Demographics, family history, premorbid functioning, developmental characteristics, and course of patients with deteriorated affective disorder. 
  • Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. 
  • Depression precipitated by alcohol use in patients with co-occurring bipolar and substance use disorders. 
  • Development of an organic affective syndrome during a hyperbaric diving experiment. 
  • Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics. 
  • Dexamethasone suppression test: a review of contemporary confusion. 
  • Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility. 
  • Diagnosis of endogenous depression. Comparison of clinical, research and neuroendocrine criteria. 
  • Diagnostic depressive symptoms of the mixed bipolar episode. 
  • Diagnostic guidelines for bipolar disorder: a summary of the International Society for Bipolar Disorders Diagnostic Guidelines Task Force Report. 
  • Differential diagnosis and pathophysiology of Cushing's syndrome and primary affective disorder. 
  • Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder. 
  • Dilemma for enhancing psychiatrists' adherence to guideline (evidence)-based practice. 
  • Dimensions of self-rated mood in depressed, manic, and normal subjects. 
  • Discerning the ancestry of European Americans in genetic association studies. 
  • Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence. 
  • Drug interaction between carbapenems and extended-release divalproex sodium in a patient with schizoaffective disorder. 
  • ECT in bipolar and unipolar depression: differences in speed of response. 
  • ECT use in unipolar and bipolar depression. 
  • EEG studies of sleep in the diagnosis of depression. 
  • Effect of 5-haplotype of dysbindin gene (DTNBP1) polymorphisms for the susceptibility to bipolar I disorder. 
  • Effectiveness of antiepileptic drugs for the treatment of bipolar disorder: findings from a systematic review. 
  • Electroconvulsive Therapy and All-Cause Mortality in Texas, 1998-2013. 
  • Electroconvulsive therapy is equally effective in unipolar and bipolar depression. 
  • Electroconvulsive therapy: an update. 
  • Elevated antisaccade error rate as an intermediate phenotype for psychosis across diagnostic categories. 
  • Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. 
  • Embryonic mania. 
  • Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. 
  • European Collaborative Project on Affective Disorders: interactions between genetic and psychosocial vulnerability factors. 
  • Evaluation of cognitive function in bipolar disorder using the Brief Assessment of Cognition in Affective Disorders (BAC-A). 
  • Evidence-based mental health use of anticonvulsants during pregnancy. 
  • Exacerbation of psychotic disorder during pregnancy in the context of medication discontinuation. 
  • Exceptionally high seizure threshold: ECT device limitations. 
  • Excess mortality in schizophrenia and affective disorders. Do suicides and accidental deaths solely account for this excess? 
  • Exercise as a treatment for depression and other psychiatric disorders: a review. 
  • Exploratory investigation of biomarker candidates for suicide in schizophrenia and bipolar disorder. 
  • Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. 
  • Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials. 
  • Eye-tracking, attention and amphetamine challenge. 
  • Factors that affect adherence to bipolar disorder treatments: a stated-preference approach. 
  • Familial leukoencephalopathy in bipolar disorder. 
  • Fighting on the side of life: a special issue on suicide in bipolar disorder. 
  • First family-based test for association of neuregulin with bipolar affective disorder. 
  • Fluoxetine response in children with autistic spectrum disorders: correlation with familial major affective disorder and intellectual achievement. 
  • Frequencies of signs and symptoms in mixed and pure episodes of mania: implications for the study of manic episodes. 
  • Funeral mania in recurrent bipolar affective disorders: reports of three cases. 
  • GABA(A) receptor alpha5 subunit as a candidate gene for autism and bipolar disorder: a proposed endophenotype with parent-of-origin and gain-of-function features,with or without oculocutaneous albinism. 
  • GERI-BD: A Randomized Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of Mania in Older Patients With Bipolar Disorder. 
  • Gabapentin in the treatment of mental illness: the echo chamber of the case series. 
  • General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial. 
  • Genes Involved in Neurodevelopment, Neuroplasticity, and Bipolar Disorder: CACNA1C, CHRNA1, and MAPK1. 
  • Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. 
  • Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB. 
  • Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders. 
  • Genome-wide association study of bipolar I disorder in the Han Chinese population. 
  • Genome-wide scan of bipolar disorder and investigation of population stratification effects on linkage: support for susceptibility loci at 4q21, 7q36, 9p21, 12q24, 14q24, and 16p13. 
  • Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania. 
  • Gray and white matter brain volumes in older adults with bipolar disorder. 
  • HIV risk behavior among patients with co-occurring bipolar and substance use disorders: associations with mania and drug abuse. 
  • High-performance liquid chromatography of haloperidol in serum at the concentrations achieved during chronic therapy. 
  • Hippocampal volume measurement in older adults with bipolar disorder. 
  • How reviews covered the unfolding scientific story of gabapentin for bipolar disorder. 
  • Hyperintense MRI lesions in bipolar disorder: A meta-analysis and review. 
  • Hyperintense lesions on magnetic resonance images in bipolar disorder. 
  • Hypocholesterolemia during mixed manic episodes. 
  • Hypomania following withdrawal of trazodone. 
  • Impact of obesity on health-related quality of life in schizophrenia and bipolar disorder. 
  • Impaired Context Processing is Attributable to Global Neuropsychological Impairment in Schizophrenia and Psychotic Bipolar Disorder. 
  • Impaired limbic gamma oscillatory synchrony during anxiety-related behavior in a genetic mouse model of bipolar mania. 
  • Influence of BDNF variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia. 
  • Influence of Criminal Justice Involvement and Psychiatric Diagnoses on Treatment Costs Among Adults With Serious Mental Illness. 
  • Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia. 
  • Informed use of the dexamethasone suppression test. 
  • Insight in schizophrenia and mania. 
  • Insight is greater in mixed than in pure manic episodes of bipolar I disorder. 
  • Integrating multiple data sources (MUDS) for meta-analysis to improve patient-centered outcomes research: a protocol. 
  • Interference by carbamazepine with the dexamethasone suppression test. 
  • International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. 
  • International prescribing patterns for mood illness: the International Mood Network (IMN). 
  • International randomized-controlled trial of transcranial Direct Current Stimulation in depression. 
  • Investigation of Notch3 as a candidate gene for bipolar disorder using brain hyperintensities as an endophenotype. 
  • Irritability in child and adolescent psychopathology: An integrative review for ICD-11. 
  • Joint analysis of psychiatric disorders increases accuracy of risk prediction for schizophrenia, bipolar disorder, and major depressive disorder. 
  • Key updates in the clinical application of electroconvulsive therapy. 
  • Largest GWAS of PTSD (N=20 070) yields genetic overlap with schizophrenia and sex differences in heritability. 
  • Late-life onset bipolar disorder presenting as a case of pseudo-dementia: a case discussion and review of literature. 
  • Leukocytosis and hypoalbuminemia in mixed bipolar states: evidence for immune activation. 
  • Levocarnitine-induced hypophosphatemia in a hemodialysis patient with acute valproic acid toxicity. 
  • Lifetime perturbations of bipolar disorder. 
  • Lithium ameliorates nucleus accumbens phase-signaling dysfunction in a genetic mouse model of mania. 
  • Lithium carbonate treatment of select behavior disorders in children suggesting manic-depressive illness. 
  • Lithium-induced behavior changes in children with symptoms suggesting manic-depressive illness. 
  • Lithium-induced nephrotic syndrome. 
  • Long-term outcome of major psychoses. I. Schizophrenia and affective disorders compared with psychiatrically symptom-free surgical conditions. 
  • Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. 
  • Low-dimensional chaos in bipolar disorder? 
  • Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. 
  • Lymphocyte numbers in endogenous depression. 
  • Magnetic resonance imaging abnormalities and psychiatric illness. 
  • Mania in Alzheimer's disease. 
  • Manic-depressive illness in children: treatment with lithium carbonate. 
  • Medical comorbidity in a bipolar outpatient clinical population. 
  • Medical comorbidity in bipolar disorder: re-prioritizing unmet needs. 
  • Medication preferences and adherence among individuals with severe mental illness and psychiatric advance directives. 
  • Medication-Assisted Treatment for Alcohol-Dependent Adults With Serious Mental Illness and Criminal Justice Involvement: Effects on Treatment Utilization and Outcomes. 
  • Mental patients' attraction to the hospital: correlates of living preference. 
  • Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. 
  • Methodologic issues in maintenance therapy clinical trials. 
  • Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders. 
  • Misdiagnoses of endogenous depression with research diagnostic criteria. 
  • Mixed depression: a study of its phenomenology and relation to treatment response. 
  • Molecular genetic and family studies in affective disorders: state of the art. 
  • Mood variability in adolescents: a study of depressed, nondepressed and comorbid patients. 
  • Mortality in patients with schizophrenia, mania, depression and surgical conditions. A comparison with general population mortality. 
  • Multiple outcomes and analyses in clinical trials create challenges for interpretation and research synthesis. 
  • National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. 
  • Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics. 
  • Neuroendocrine evaluation of depression in borderline patients. 
  • Neuroendocrine identification of depressed patients. 
  • Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction. 
  • Neuropathology in affective illness. 
  • Neuroplasticity, Neurotransmission and Brain-Related Genes in Major Depression and Bipolar Disorder: Focus on Treatment Outcomes in an Asiatic Sample. 
  • Neuropsychiatric problems after traumatic brain injury: unraveling the silent epidemic. 
  • Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. 
  • Neurosteroid Levels in Patients With Bipolar Disorder and a History of Cannabis Use Disorders. 
  • Normalization of dexamethasone suppression test: a laboratory index of recovery from endogenous depression. 
  • Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders. 
  • Nutrition and Bipolar Depression. 
  • Occurrence of subcortical hyperintensities in elderly subjects with mania. 
  • Parental relationships and behavioral approach system dysregulation in young adults with bipolar disorder. 
  • Pathologic assessment of cerebellar atrophy following acute lithium intoxication. 
  • Patterns of justice involvement among adults with schizophrenia and bipolar disorder: key risk factors. 
  • Patterns of pharmacotherapy and treatment response in elderly adults with bipolar disorder. 
  • Performance of a weight-related measure of Quality of Life in a psychiatric sample. 
  • Personality assessment inventory internalizing and externalizing structure in veterans with posttraumatic stress disorder: associations with aggression. 
  • Pharmacotherapy of bipolar disorder in old age: review and recommendations. 
  • Plasma corticosterone in dexamethasone suppression test on depressed patients. 
  • Plasma dexamethasone concentration and cortisol response during manic episodes. 
  • Platelet monoamine oxidase activity and the classification of depression. 
  • Polypharmacy in pregnant women with major psychiatric illness: a pilot study. 
  • Practitioner review: the assessment of bipolar disorder in children and adolescents. 
  • Prediction of treatment outcome with lithium. 
  • Premature deaths in schizophrenia and affective disorders. An analysis of survival curves and variables affecting the shortened survival. 
  • Prevalence of HIV infection in a general psychiatric outpatient population. 
  • Prevalence of antithyroid antibodies in mood disorders 
  • Prevalence of baseline lipid monitoring in patients prescribed second-generation antipsychotics during their index hospitalization: a retrospective cohort study. 
  • Prevention of postpartum episodes in women with bipolar disorder. 
  • Prioritization of research addressing antipsychotics for adolescents and young adults with bipolar disorder. 
  • Proceedings: Role of acetylcholine and dopamine in manic behavior. 
  • Prolactin-related and metabolic adverse effects of atypical antipsychotic agents. 
  • Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: implications for the development of novel therapeutics for bipolar disorder. 
  • Psychiatric and medical comorbidities of bipolar disorder. 
  • Psychiatric episodes in women with young children. 
  • Psychotherapeutic Treatment of Bipolar Depression. 
  • Pure and mixed manic subtypes: a review of diagnostic classification and validation. 
  • Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study. 
  • Quinone oxidoreductase (NQO1) gene polymorphism may not confer a susceptibility to mood disorders. 
  • Recurrent premenstrual decline in serum lithium concentration: clinical correlates and treatment implications. 
  • Reduced white matter integrity and verbal fluency impairment in young adults with bipolar disorder: a diffusion tensor imaging study. 
  • Reducing barriers to completing psychiatric advance directives. 
  • Regressing to Prior Response Preference After Set Switching Implicates Striatal Dysfunction Across Psychotic Disorders: Findings From the B-SNIP Study. 
  • Religiosity, depression, and quality of life in bipolar disorder: a two-year prospective study. 
  • Resting-state brain function in schizophrenia and psychotic bipolar probands and their first-degree relatives. 
  • Risk factors of attempted suicide in bipolar disorder. 
  • Role of treatment alliance in the clinical management of bipolar disorder: stronger alliances prospectively predict fewer manic symptoms. 
  • Safety and tolerability of lamotrigine: results from 12 placebo-controlled clinical trials and clinical implications. 
  • Safety considerations in pharmacotherapy of bipolar disorder. 
  • Safety of antipsychotics in the setting of QTc prolongation: the utility of the JT index. 
  • Scopolamine sleep treatment in private practise. 
  • Seasonal variation of mixed and pure episodes of bipolar disorder. 
  • Seizure threshold in electroconvulsive therapy (ECT) II. The anticonvulsant effect of ECT. 
  • Seizure threshold in electroconvulsive therapy: I. Initial seizure threshold. 
  • Separation of subtypes of depression using discriminant analysis. I. Separation of unipolar endogenous depression from non-endogenous depression. 
  • Separation of subtypes of depression using discriminant analysis. Separation of bipolar endogenous depression from nonendogenous ("Neurotic") depression. 
  • Serial dexamethasone suppression tests among rapidly cycling bipolar patients. 
  • Serum bupropion levels in 2 breastfeeding mother-infant pairs. 
  • Serum valproate levels in 6 breastfeeding mother-infant pairs. 
  • Short-term and long-term treatment for bipolar patients: beyond the guidelines. 
  • Short-term variability of mood ratings in unipolar and bipolar depressed patients. 
  • Signs and symptoms of mania in pure and mixed episodes. 
  • Sleep disturbance in euthymic bipolar patients. 
  • Sleep disturbance in psychiatric disorders: effects on function and quality of life in mood disorders, alcoholism, and schizophrenia. 
  • Sleep impairment, mood symptoms, and psychosocial functioning in adolescent bipolar disorder. 
  • Smoking and psychosis in patients with bipolar I disorder. 
  • Social support in elderly patients with bipolar disorder. 
  • Social support in late life mania: GERI-BD. 
  • Speech pause time: a marker of psychomotor retardation among endogenous depressives. 
  • Stability of psychiatric diagnosis. Schizophrenia and affective disorders followed up over a 30- to 40-year period. 
  • Stressful life events in older bipolar patients. 
  • Structural changes in the brain of patients with bipolar affective disorder by MRI: a review of the literature. 
  • Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data. 
  • Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. 
  • Study design and methodology for a multicentre, randomised controlled trial of transcranial direct current stimulation as a treatment for unipolar and bipolar depression. 
  • Stutter exacerbated by lithium in a pediatric patient with bipolar disorder. 
  • Subcortical hyperintensities on brain magnetic resonance imaging: a comparison of normal and bipolar subjects. 
  • Substance abuse in bipolar disorder. 
  • Subtypes of mania determined by grade of membership analysis. 
  • Suicide Behaviors in Bipolar Disorder: A Review and Update for the Clinician. 
  • Suicide attempts in veterans with bipolar disorder during treatment with lithium, divalproex, and atypical antipsychotics. 
  • Suicide in pregnancy. 
  • Symptom factors and clinical subtypes in mania. 
  • Symptom profile consistency in recurrent manic episodes. 
  • Symptomatic remission in patients with bipolar mania: results from a double-blind, placebo-controlled trial of risperidone monotherapy. 
  • Symptomatology of affective and psychotic illnesses related to childbearing. 
  • Symptoms do not helpfully distinguish unipolar and bipolar depression. 
  • Temporal lobe volume in bipolar disorder: relationship with diagnosis and antipsychotic medication use. 
  • The Brief Assessment of Cognition In Affective Disorders (BAC-A):performance of patients with bipolar depression and healthy controls. 
  • The Challenge of Bipolar Depression in the 21st Century. 
  • The Impact of a Single Nucleotide Polymorphism in SIGMAR1 on Depressive Symptoms in Major Depressive Disorder and Bipolar Disorder. 
  • The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. 
  • The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. 
  • The MATRICS consensus cognitive battery in patients with bipolar I disorder. 
  • The Use of Antidepressants in Bipolar Depression. 
  • The clinical epidemiology of pure and mixed manic episodes. 
  • The dexamethasone suppression test and quantitative cerebral anatomy in depression. 
  • The dexamethasone suppression test for melancholia. 
  • The dexamethasone suppression test in borderline personality disorder. 
  • The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry. 
  • The effect of cognitive functioning on treatment attendance and adherence in comorbid bipolar disorder and cocaine dependence. 
  • The effect of surgery on intraocular pressure fluctuations with electroconvulsive therapy in a patient with severe glaucoma. 
  • The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. 
  • The highs and lows of amygdala reactivity in bipolar disorders. 
  • The importance of nicotinic acetylcholine receptors in schizophrenia, bipolar disorder and Tourette's syndrome. 
  • The intricate link between violence and mental disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. 
  • The iowa structured psychiatric interview. Rationale, reliability, and validity. 
  • The oxidative activity of blood serum in schizophrenic and manic-depressive psychoses. 
  • The performance of DSM-III-R major depression criteria in the diagnosis of bipolar mixed states. 
  • The relationship of bipolar disorder lifetime duration and vascular burden to cognition in older adults. 
  • The relationship of manic episodes and drug abuse to sexual risk behavior in patients with co-occurring bipolar and substance use disorders: a 15-month prospective analysis. 
  • The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trials. 
  • Thyroid function in mixed and pure manic episodes. 
  • Transcriptome analysis of cortical tissue reveals shared sets of downregulated genes in autism and schizophrenia. 
  • Treatment participation and medication adherence: effects on criminal justice costs of persons with mental illness. 
  • Tryptophan depletion in recently manic patients treated with lithium. 
  • Tyrosine hydroxylase polymorphism and phenotypic heterogeneity in bipolar affective disorder: a multicenter association study. 
  • Unipolar depression does not moderate responses to the Sweet Taste Test. 
  • Unitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relatives. 
  • Urinary excretion of biopterin and neopterin in psychiatric disorders. 
  • Urinary free cortisol excretion in depression. 
  • Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder. 
  • Utility of the proportional-hazards model for survival analysis of psychiatric data. 
  • Vascular risk factors in late onset mania. 
  • Verapamil treatment for women with bipolar disorder. 
  • Volumetric brain imaging studies in the elderly with mood disorders. 
  • White matter abnormalities in bipolar disorder: insights from diffusion tensor imaging studies. 
  • White matter hyperintensity on magnetic resonance imaging: clinical and neuroanatomic correlates in the depressed elderly. 
  • Who are the new users of antipsychotic medications? 
  • Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairment. 
  • Ziprasidone-associated mania: a case series and review of the mechanism. 
  • miR-149 and miR-29c as candidates for bipolar disorder biomarkers. 
• 

  Keywords of People

  • Bradford, Daniel William, Associate Professor of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Social and Community Psychiatry
  • McClintock, Shawn Michael, Adjunct Associate Professor in the Department of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Brain Stimulation and Neurophysiology
  • Olsen, Maren Karine, Associate Professor of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics